What clinicians need to know about psychedelic medicine
“What these substances have in common is that they are widely considered to fall into the category of psychedelics. What else they have in common is that the vast majority of us physicians learned nothing about them in medical school or residency, as most psychedelics are classified as Schedule 1 substances, which suggests they have no currently accepted medical use and pose a high potential for abuse.
With these psychedelic-based therapies, clinicians are now presented with options to help patients who haven’t benefited from traditional treatments. These therapies are vastly different from current medical models in that there is generally no pill to take every day, and some treatments need to be done only one or two times to have a lasting effect.
As some psychedelic therapies are already available, and more are coming soon, now is the time for us to get up to speed on what these psychedelic medicines are, how they work, what conditions they may be able to treat, how they interact with other medications, possible dangers, and what our role may be in facilitating patient access to these medicines.”
Lynn Marie Morski is a physician, attorney, and president, Psychedelic Medicine Association.
She shares her story and discusses her KevinMD article, “What doctors need to know about psychedelic medicine.”
Did you enjoy today’s episode?
Rate and review the show so more audiences can find The Podcast by KevinMD.
Subscribe on your favorite podcast app to get notified when a new episode comes out.
Reflect and earn 1.0 AMA PRA Category 1 CME for this episode.
Also available in Category 1 CME bundles.
Powered by CMEfy – a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info
